These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21606627)

  • 1. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
    Hashimoto M; Hossain S
    J Pharmacol Sci; 2011; 116(2):150-62. PubMed ID: 21606627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats.
    Hashimoto M; Tanabe Y; Fujii Y; Kikuta T; Shibata H; Shido O
    J Nutr; 2005 Mar; 135(3):549-55. PubMed ID: 15735092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.
    Yurko-Mauro K
    Curr Alzheimer Res; 2010 May; 7(3):190-6. PubMed ID: 20088810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic Acid-Phosphatidylcholine Improves Cognitive Deficits in an Aβ23-35-Induced Alzheimer's Disease Rat Model.
    Qu MH; Yang X; Wang Y; Tang Q; Han H; Wang J; Wang GD; Xue C; Gao Z
    Curr Top Med Chem; 2016; 16(5):558-64. PubMed ID: 26268328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats.
    Hashimoto M; Hossain S; Shimada T; Sugioka K; Yamasaki H; Fujii Y; Ishibashi Y; Oka J; Shido O
    J Neurochem; 2002 Jun; 81(5):1084-91. PubMed ID: 12065621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK.
    Vela S; Sainz N; Moreno-Aliaga MJ; Solas M; Ramirez MJ
    Mol Neurobiol; 2019 Mar; 56(3):1618-1627. PubMed ID: 29911253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.
    Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV
    Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid: one molecule diverse functions.
    Hashimoto M; Hossain S; Al Mamun A; Matsuzaki K; Arai H
    Crit Rev Biotechnol; 2017 Aug; 37(5):579-597. PubMed ID: 27426008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation.
    Lee AY; Lee MH; Lee S; Cho EJ
    J Agric Food Chem; 2017 Dec; 65(49):10719-10729. PubMed ID: 29092397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
    Oster T; Pillot T
    Biochim Biophys Acta; 2010 Aug; 1801(8):791-8. PubMed ID: 20211757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
    Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
    J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
    Quinn JF; Raman R; Thomas RG; Yurko-Mauro K; Nelson EB; Van Dyck C; Galvin JE; Emond J; Jack CR; Weiner M; Shinto L; Aisen PS
    JAMA; 2010 Nov; 304(17):1903-11. PubMed ID: 21045096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
    Cole GM; Frautschy SA
    Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells.
    Hashimoto M; Katakura M; Hossain S; Rahman A; Shimada T; Shido O
    J Nutr Biochem; 2011 Jan; 22(1):22-9. PubMed ID: 20226652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
    Lim GP; Calon F; Morihara T; Yang F; Teter B; Ubeda O; Salem N; Frautschy SA; Cole GM
    J Neurosci; 2005 Mar; 25(12):3032-40. PubMed ID: 15788759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions.
    Hashimoto M; Hossain S; Agdul H; Shido O
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):91-8. PubMed ID: 16427803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
    Pauwels EK; Volterrani D; Mariani G; Kairemo K
    Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
    Pan Y; Choy KHC; Marriott PJ; Chai SY; Scanlon MJ; Porter CJH; Short JL; Nicolazzo JA
    J Neurochem; 2018 Jan; 144(1):81-92. PubMed ID: 29105065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers.
    Florent S; Malaplate-Armand C; Youssef I; Kriem B; Koziel V; Escanyé MC; Fifre A; Sponne I; Leininger-Muller B; Olivier JL; Pillot T; Oster T
    J Neurochem; 2006 Jan; 96(2):385-95. PubMed ID: 16300635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.